Non-Randomized Trial of Bruxism-Related TMD Treatments

NCT07586072 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Bruxism
Temporomandibular Disorders (TMD)
Myofascial Pain

Interventions

DEVICE: Occlusal splint
DRUG: Botulinum Toxin Type A (Dysport®)
DRUG: Thiocolchicoside
DRUG: tenoxicam

Sponsor

Recep Tayyip Erdogan University